Ajanta Pharma to hold 47th AGM on July 16, 2026, via VC/OAVM
Ajanta Pharma Limited will hold its 47th Annual General Meeting on July 16, 2026, at 11:00 a.m. IST via Video Conferencing. The cut-off date for voting eligibility is July 9, 2026. The Annual Report for FY 2025-26 will be dispatched shortly.
The announcement of an AGM date is a standard corporate procedure and does not typically have a significant short-term impact on the company's stock price or business operations.
The announcement is a routine corporate event (AGM) with no immediate financial implications. It is a procedural update.
Ajanta Pharma Limited has announced that its Forty-Seventh (47th) Annual General Meeting (AGM) will be conducted on Thursday, July 16, 2026, commencing at 11:00 a.m. (IST). The meeting will be held entirely through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), in adherence to the Companies Act, 2013, and relevant circulars from the Ministry of Corporate Affairs and SEBI.
The company will consider the beneficiary position of shareholders as of Friday, June 12, 2026, for the dispatch of the Annual Report for FY 2025-26 and the AGM notice. The cut-off date for determining shareholder eligibility to vote on the resolutions at the AGM has been set as Thursday, July 9, 2026.
The official notice for the AGM and the Annual Report for FY 2025-26 will be distributed to shareholders in due course and will also be accessible on the company's website.
What to do with a filing like this
Ajanta Pharma Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Ajanta Pharma Limited. Read the original for the full detail.